PMID: 9187828Jun 1, 1997Paper

Nonpulmonary medical complications in the intermediate and long-term survivor

Clinics in Chest Medicine
J R Maurer, S Tewari

Abstract

This article deals with the nonpulmonary, non-infectious complications in intermediate and long-term survivors of lung transplantation. Although they are an infrequent cause of mortality, these disorders can cause significant morbidity in this population. Diseases associated with the gamut of medications used post-transplant are specifically discussed, as are diseases caused by the direct immunosuppressive action of some of these drugs. General care of transplant patients also entails attention to their underlying diseases, and to routine medical considerations common to all patients.

References

Oct 1, 1979·Annals of Internal Medicine·D C CattranS A Fenton
Nov 1, 1992·Transplantation·J S ZaltzmanD C Cattran
Aug 15, 1992·The American Journal of Cardiology·S H KuboD B Hunninghake
Dec 1, 1991·Critical Care Medicine·S H SubramonyO B Evans
Nov 1, 1991·Journal of the American Society of Nephrology : JASN·I DawidsonF Seney
Aug 22, 1991·The New England Journal of Medicine·B A JulianL D Quarles
Sep 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D E HricikJ A Schulak
Jun 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B L KasiskeK V Rao
Aug 9, 1990·The New England Journal of Medicine·R L Hughes
Sep 13, 1990·The New England Journal of Medicine·U ScherrerR G Victor
Mar 1, 1990·Annals of Internal Medicine·B P Lukert, L G Raisz
May 1, 1985·Transplantation·D W HantoR L Simmons
May 19, 1988·The New England Journal of Medicine·R S ShapiroA Filipovich
Jan 7, 1988·The New England Journal of Medicine·D J NormanJ Hosenpud
Jan 7, 1988·The New England Journal of Medicine·C EastJ A Farmer
Feb 1, 1988·Kidney International·B D MyersN S Coplon
Jul 8, 1988·JAMA : the Journal of the American Medical Association·C L CorpierJ B Young
Oct 1, 1987·The New England Journal of Medicine·P C de GroenR A Krom
Aug 1, 1988·The American Journal of Medicine·W M Bennett, G A Porter
Oct 9, 1982·Lancet·S DurrantE C Gordon-Smith
Oct 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J M PattisonJ Theodore
Aug 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·T J KroshusR M Bolman
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V LeblondA Fischer
Dec 15, 1994·The New England Journal of Medicine·E E Weinmann, E W Salzman
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·M DecramerP Rogiers

❮ Previous
Next ❯

Citations

Mar 22, 2001·The British Journal of Surgery·H J HoekstraW van der Bij
May 25, 2002·Kidney International·Areef IshaniMark E Rosenberg
Jul 11, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M CanalesH N Ibrahim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.